ConductScience.org, home

Library / Genes

MYC: MYC proto-oncogene, bHLH transcription factor

1 protein, 371 patents, 0 drugs, 0 trials, 42,341 NIH grants and 137,878 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolMYCHGNC
NameMYC proto-oncogene, bHLH transcription factorHGNC
NCBI Gene ID4609NCBI Gene
HGNC IDHGNC:7553HGNC
EnsemblENSG00000136997NCBI Gene
AliasesMRTL, MYCC, bHLHe39, c-MycNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P01106Myc proto-oncogene protein45425Ensembl, GeneID, HGNCUniProt

Patents 371

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4827841 A12026-10-281P01106Espacenet
WO 2026171881 A12026-08-207P01106Espacenet
JP 2026091847 A2026-06-048P01106Espacenet
JP 2026514551 A2026-05-122P01106Espacenet
JP 2026514202 A2026-05-072P01106Espacenet
EP 4733399 A12026-04-2912P01106Espacenet
EP 4705273 A22026-03-1111P01106Espacenet
US 12559772 B22026-02-244P01106Espacenet
WO 2026024954 A22026-01-2955P01106Espacenet
WO 2025235563 A12025-11-1327P01106Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 42341

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant1,1362,025NIH's project files
P30CA008748Cancer Center Support Grant9772,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)2522,025NIH's project files
P30CA016058Cancer Center Support Grant2222,025NIH's project files
P30CA006973Regional Oncology Research Center2202,025NIH's project files
P30CA068485Cancer Center Support Grant1782,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant1742,025NIH's project files
P30CA060553The Robert H. Lurie Comprehensive Cancer Center1702,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program1672,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant1622,025NIH's project files

Papers 137878

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826715PubTator, text miningPubMed
42824816PubTator, text miningPubMed
42823884PubTator, text miningPubMed
42822446PubTator, text miningPubMed
42822254PubTator, text miningPubMed
42822006PubTator, text miningPubMed
42819443PubTator, text miningPubMed
42818890PubTator, text miningPubMed
42818566PubTator, text miningPubMed
42817838PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license